Thus, the D-bLP + laser/M-bLP treatment could abate the enrichment of CSCs fractions and inhibit the self-renewal capacity, holding great premise to suppress tumor relapse and metastasis. The gene discussed is DYNLRB1; the disease is neoplasm.